47
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Dysregulation of Apoptosis and a Novel Mechanism of Defective Apoptotic Signal Transduction in Human B-cell Neoplasms

, &
Pages 243-249 | Published online: 01 Jul 2009

  • Evan, G. and Littlewood, T. (1998) "A matter of life and cell death",Science 281, 1317-1321.
  • Fisher, D.E. (1994) "Apoptosis in cancer therapy: crossing thethreshold", Cell 78, 539-542
  • Lowe, S.W., Ruley, H.E., Jacks, T. and Housman, D.E. (1993) "p53-dependent apoptosis modulates the cytotoxicity of anticancer agents", Cell 74, 957-967.
  • Korsmeyer, S.J. (1992) "Bcl-2: A repressor of lymphocyte death",Immunol, Today 13, 285-288.
  • Levine, A.J., Momand, J. and Finlay, C.A. (1991) "The p53 tumoursuppressor gene", Nature 351, 453-456.
  • Melchers, F. and Rolink, A. (1999) "B-lymhocyte development and biology", In: Paul, E., ed, Fundamental Immunology (LippincottRaven, Philadelphia), pp 183-224.
  • Surh, C.D. and Sprent, J. (1994) "T-cell apoptosis detected in situ during positive and negative selection in the thymus", Nature 372, 100-103.
  • Clayton, L.K., Ghendler, Y., Mizoguchi, E., Patch, R.J., Ocain, T.D., Orth, K., Bhan, A.K., Dixit, V.M. and Reinherz, E.L. (1997) "T-cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: the molecular basis of negative selection". EMBO J. 16, 2282-2293.
  • Lang, J., Arnold, B., Hammerling, G., Harris, A.W., Korsmeyer, S., Russell, D., Strasser, A. and Nemazee, D. (1997) "Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells", J. Exp. Med. 186. 1513-1522.
  • Andjelic, S. and Liou, H.C. (1998) "Antigen receptor-induced B lymphocyte apoptosis mediated via a protease of the caspase family", Eur. J. Immunol. 28, 570-581.
  • Melamed, D. and Nemazee, D. (1997) "Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest", Proc. Natl. Acad. Sci. USA 94, 9267-9272.
  • Martinez-Valdez, H., Guret, C., de Bouteiller, O., Fugier, L, Banchereau, J. and Liu, Y.J. (1996) "Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2", J. Exp. Med. 183. 971-977.
  • Han, S., Zheng, B., Dal Porto, J. and Kelsoe, G. (1995) "In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance", J. Exp. Med. 182, 1635-1644.
  • Adams, J.M. and Cory, S. (1998) "The Bcl-2 protein family: Arbiters of cell survival", Science 281, 1322-1326.
  • Yang, E., Zha, J., Jockel, J., Boise, L.H., Thompson, C.B. and Korsmeyer, S.J. (1995) "Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death", Cell 80, 285-291.
  • Motoyama, N., Wang, F., Roth, K.A., Sawa, H., Nakayama, K., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., et al. (1995) "Massive cell death of immature bematopoietic cells and neurons in Bcl-x-deficient mice". Science 267, 1506-1510.
  • Chao, D., Linette, G.P., Boise, L.H., White, L.S., Thompson, C.B. and Korsmeyer, S.J. (1995) "Bcl-xL and Bcl-2 repress a common pathway of cell death", J. Exp. Med. 182, 821-828.
  • Veis, D.J., Sorenson, C.M., Shutter, J.R. and Korsmeyer, S.J. (1993) "Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosie, polycystic kidneys, and hypopigmented hair", Cell 75, 229-240.
  • Nakayama, K-I., Nakayama, K., Negishi, L., Kuida, K., Shinkai, Y., Louie, M.C., Fields, L.E., Lucas, P.J., Stewart, V., Alt, F.W., et al. (1993) "Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice", Science 261, 1584-1588.
  • Reed, J.C., Miyashita, T., Cuddy, M. and Cho, D. (1992) "Regulation of p26-bcl-2 protein levels in human peripheral blood lymphocytes", Lab. Invest. 67, 443-449.
  • Kroemer, G., Zamzami, N. and Susin, A.S. (1997) "Mitochondrial control of apoptosis". Immunol. Today 18, 44-51.
  • Zamzami, N., Marehetti, P. Castedo, M., Zanin, C., Vayssiere, J., Petit, X.P. and Kroemer, G. (1995) "Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo", J. Exp. Med. 181, 1661-1672.
  • Bouchon, A., Krammer, P.H. and Walczak, H. (2000) "Critical role for mitochondria in B cell receptor-mediated apoptosis", Eur. J. Immunol. 30, 69-77.
  • Kroemer, G. and Reed, J.C. (2000) "Mitochondrial control of death", Nature Med. 6, 513-519.
  • Shimizu, S. and Tsujimoto, Y. (2000) "Proapoptotic BH3-only Bcl-2 family members induce cytochrome release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity", Proc.Natl.Acad. Sci USA 97, 577-582.
  • Li, P., Nijhawan, D., Budihardjo, L, Srinivasula, S.M., Ahmad, M., Alnemri, E.S. and Wang, X. (1997) "Cytochrome C and dATP-dependent formation of apaf-1/caspase-9 complex initiates an apoptotic protease cascade", Cell 91, 479-489.
  • Susin, S.A., Zamzami, N., Marchetti, P., Hirsch, T., Gomes-Monterrey, L, Castedo, M. and Kroemer, G. (1996) "Bcl-2 inhibits the mitochondrial release of an apoptogenic protease", J. Exp. Med. 184, 1331-1341.
  • Li, H., Zhu, H., Xu, C. and Yuan, J. (1998) "Cleavage of BID by caspase 8 mediate the mitochondrial damage in the Fas pathway of apoptosia", Cell 94, 491-501.
  • Luo, X., Budihardjo, L, Zou, H., Slaughter, C. and Wang, X. (1998) "Bid, a Bcl-2 interacting protein, mediates cytochrome c release in response to activation of cell surface death receptors", Cell 94, 481-490.
  • Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A. and Nagata, S. (1998) "A caspase-activated DNAse that degrades DNA during apoptosis, and its inhibitor ICAD", Nature 391,43-50.
  • Sakahira, H., Enari, M. and Nagata, S. (1998) "Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis", Nature 391, 96-99.
  • Liu, X., Zou, H., Slaughter, C. and Wang, X. (1997) "DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis". Cell 89, 175-184.
  • Tsujimoto, Y., Cossman, J., Jaffe, E. and Croce, CM. (1985) "Involvement of the bcl-2 gene in human follicular lymphoma", Science 228, 1440-1443.
  • Tsujimoto, Y., Bashir, M.M., Givol, L, Cossman, J., Jaffe, E. and Croce, C.M. (1987) "DNA rearrangements in human follicular lymphoma can involve the 5' or the 3' region of the bcl-2 gene", Proc. Natl. Acad. Sci. USA 84, 1329-1331.
  • Zutter, M., Hockenbery, D., Silverman, G.A. and Korsmeyer, S.J. (1991) "Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms", Blood 78, 1062-1068.
  • Adachi, M., Tafferi, A., Greipp, P.R., Kipps, T.J. and Tsujimoto, Y. (1990) "Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia", J. Exp. Med. 171, 559-564.
  • Tashiro, S., Takechi, M., Asou, H., Takauchi, K., Kyo, T., Dohy, H., Kikuchi, M., Kamada, N. and Tsujimoto, Y. (1992) "Cytogenetic 2; 18 and 18; 22 translocation in chronic lymphocytic leukemia with juxtaposition of bcl-2 and immunoglobutin light chain genes", Oncogene 7, 573-577.
  • Pepper, C., Hoy, T. and Bentley, D.P. (1997) "Bcl-2/Bax ratios in chronic lymphocytic leukemia and their correlation with in vitro apoptosis and clinical resistance", Br. J. Cancer 76, 935-938.
  • Tu, Y., Renner, S., Xu, F., Fleishman, A., Taylor, J., Weisz, J., Vescio, R., Rettig, M., Berenson, J., Krajewski, S., Reed, J.C. and Lichtenstein, A. (1998) "BCL-X expression in multiple myeloma: possible indicator of chemoresistance", Cancer Res. 58, 256-262.
  • Prokop, A., Wieder, T., Sturm, L, Essmann, F., Seeger, K., Wuchter, C., Ludwig, W.D., Henze, G., Dorken, B. and Daniel, P.T. (2000) "Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo", Leukemia 14, 1606-1613.
  • Kuppers, R., Klein, U., Hansmann, M. and Rajewsky, K. (1999) "Cellular origin of human B-cell lymphomas", N.Eng. J. Med. 341, 1520-1529.
  • Schlaifer, D., March, M., Krajewsld, S., Laurent, G., Prie, J., Delsol, G., Reed, J.C. and Brousset, P. (1995) "High expression of the bcl-x gene in Reed-Stemherg cells of Hodgkin's disease", Blood 85, 2671-2674.
  • [43| Hansen, R. and Oren, M. (1997) "p53; From inductive signal to cellular effect", Curr. Opin. Genet. Dev. 7, 46-51.
  • Yin, C., Knudson, C.M., Korsmeyer, S.J. and Van Dyke, T. (1997) "Bax suppresses tumorigenesis and stimulates apoptosis in vivo", Nature 385, 637-640.
  • Zhan, Q., Fan, S., Bae, L., Guillouf, C., Liebermann, D.A., O'Connor, P.M., Fornace, A.J., et al. (1994) "Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis", Oncogene 9, 3743-3751.
  • McCurrach, M.E., Connor, T.M., Knudson, C.M., Korsmeyer, S.J. and Lowe, S.W. (1997) "Bax-deficiency promotes drug resistance, oncogenic transformation by attenuating p53-dependent apoptosis". Proc. Natl. Acad. Sci. USA 94, 2345-2349.
  • Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B.R. and Kley, N. (1995) "Induction of the growth inhibitor IGF-binding protein 3 by p53", Nature 377, 646-649.
  • Ludwig, R.L., Bates, S. and Vousden, K.H. (1996) "Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function", Mol. Cell. Biol. 16, 4952-4960.
  • Venot, C., Maratrat, M., Dureuil, C., Conseiller, E., Bracco, L. and Debussche, L. (1998) "The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression", EMBO J. 17,4668-4679.
  • Ichikawa, A., Kinoshita, T., Watanabe, T., Kato, H., Nagai, H., Tsushita, K., Saito, H. and Hotta, T. (1997) "Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma", N. Engl. J. Med. 337, 529-534.
  • Dohner, H., Fiecher, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., et al (1995) "p53 gene deletion, predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias", Blood 85, 1580-1589.
  • Gaidano, G., Ballerini, P., Gong, J.Z., lnghirami, G., Neri, A., Newcomb, E.W., Magrath, I.T., Knowles, D.M. and Dalla-Favera, R. (1991) "p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia", Proc. Natl. Acad. Sci. USA 88, 5413-5417.
  • Pinyol, M., Hernandez, L., Martinez, A., Cobo, F., Hernandez, S., Bea, S., Lopez-Guillermo, A., Nayach, I., Palacin, A., Nadal, A., Fernandez, P.L., Montserrat, E., Cardesa, A. and Campo, E. (2000) "INK4a/ARF locus alterations in human non-Hodgkin's lympho-mas mainly occur in tumors with wild-type p53 gene", Am. J. Pathol. 156, 1987-1996.
  • Watanabe, T., Hotta, T., Ichikawa, A., Kinoshita, T., Nagai, H., Uchida, T., Murate, T. and Saito, H. (1994) "The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin", Blood 84, 3158-3165.
  • Ashcroft, M. and Vousden, K.H. (1999) "Regulation of p53 stability", Oncogene 18, 7637-7643.
  • Midgley, C.A., Desterro, J.M., Saville, M.K., Howard, S., Sparks, A., Hay, R.T. and Lane, D.P. (2000) "An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo", Oncogene 19, 2312-2323.
  • Kuroki, J., Hirokawa, M., Kitabayashi, A., Lee, M. and Miura, A.B. (1996) "Cell-permeable ceramide inhibits the growth of TNF-a resistant B lymphoma cells by inducing GO/Gl arrest but not apoptosis: a new model for dissecting cell-cycle arrest and apoptosis", Leukemia 10, 1950-1958
  • Hirokawa, M., Kitabayashi, A., Kuroki, J. and Miura, A.B. (2000) "Induction of tissue factor production but not the upregulation of adhesion molecule expression by ceramide in human vascular endothelial cells", Tohoku J. Exp. Med. 191, 167-176.
  • Kawabata, Y., Hirokawa, M., Kitabayashi, A., Horiuchi, T., Kuroki, J. and Miura, A.B. (1999) "Defective apoptotic signal transduction pathway downstream of caspase-3 in human B lymphoma cells: a novel mechanism of nuclear apoptosis resistance", Blood 94, 3523-3530.
  • Druker, B.J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G.M., Fanning, S., Zimmermann, J. and Lydon, N.B. (1996) "Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcrabl positive cells", Nat. Med. 2, 561-566.
  • Druker, B.J. and Lydon, N.B. (2000) "Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia", J. Clin. Invest. 105, 3-7.
  • Amarante-Mendes, G.P., Kim, C.N., Liu, L., Huan, Y., Perkins, C.L., Green, D.R. and Bhalla, K. (1998) "Bcr-abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3", Blood 91, 1700 1705.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.